Immuron Limited (ASX:IMC)
Australia · Delayed Price · Currency is AUD 0.0340
-0.0020 (-5.56%)
Aug 5, 2026, 3:57 PM AEST
Immuron Market Cap
Immuron has a market cap or net worth of 10.45 million as of August 5, 2026. Its market cap has decreased by -42.69% in one year.
Market Cap
10.45M
Enterprise Value
661.51K
Revenue
7.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since September 14, 1999, Immuron's market cap has decreased from 37.31M to 10.45M, a decrease of -71.98%. That is a compound annual growth rate of -4.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 11.76M | 0.35% |
| Dec 31, 2025 | 11.72M | -35.27% |
| Dec 30, 2024 | 18.10M | 3.20% |
| Dec 29, 2023 | 17.54M | -10.47% |
| Dec 30, 2022 | 19.59M | -14.00% |
| Dec 31, 2021 | 22.78M | -56.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 22.30M |
| Patrys | 22.00M |
| EZZ Life Science Holdings | 21.89M |
| Argenica Therapeutics | 19.91M |
| Ceryvyn Therapeutics | 16.42M |
| ReNerve | 14.65M |
| AdAlta | 11.24M |
| Cambium Bio | 11.21M |